Annual CFO
-$40.62 M
-$6.49 M-19.03%
31 December 2023
Summary:
Compass Therapeutics annual cash flow from operations is currently -$40.62 million, with the most recent change of -$6.49 million (-19.03%) on 31 December 2023. During the last 3 years, it has fallen by -$13.81 million (-51.54%). CMPX annual CFO is now -106.54% below its all-time high of -$19.67 million, reached on 31 December 2021.CMPX Cash From Operations Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly CFO
-$11.05 M
-$297.00 K-2.76%
01 September 2024
Summary:
Compass Therapeutics quarterly cash flow from operations is currently -$11.05 million, with the most recent change of -$297.00 thousand (-2.76%) on 01 September 2024. Over the past year, it has dropped by -$5.13 million (-86.61%). CMPX quarterly CFO is now -219.67% below its all-time high of -$3.46 million, reached on 01 September 2021.CMPX Quarterly CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM CFO
-$48.05 M
-$5.13 M-11.95%
01 September 2024
Summary:
Compass Therapeutics TTM cash flow from operations is currently -$48.05 million, with the most recent change of -$5.13 million (-11.95%) on 01 September 2024. Over the past year, it has dropped by -$9.14 million (-23.50%). CMPX TTM CFO is now -519.08% below its all-time high of -$7.76 million, reached on 01 March 2020.CMPX TTM CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
CMPX Cash From Operations Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -19.0% | -86.6% | -23.5% |
| 3 y3 years | -51.5% | -219.7% | -122.7% |
| 5 y5 years | -20.6% | - | - |
CMPX Cash From Operations High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -106.5% | at low | -219.7% | +20.4% | -144.3% | at low |
| 5 y | 5 years | -106.5% | at low | -219.7% | +20.4% | -519.1% | at low |
| alltime | all time | -106.5% | at low | -219.7% | +20.4% | -519.1% | at low |
Compass Therapeutics Cash From Operations History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$11.05 M(+2.8%) | -$48.05 M(+12.0%) |
| June 2024 | - | -$10.75 M(-22.6%) | -$42.92 M(+1.5%) |
| Mar 2024 | - | -$13.89 M(+12.4%) | -$42.28 M(+4.1%) |
| Dec 2023 | -$40.62 M(+19.0%) | -$12.35 M(+108.6%) | -$40.62 M(+4.4%) |
| Sept 2023 | - | -$5.92 M(-41.4%) | -$38.91 M(-11.4%) |
| June 2023 | - | -$10.11 M(-17.3%) | -$43.92 M(+14.4%) |
| Mar 2023 | - | -$12.23 M(+14.9%) | -$38.41 M(+12.6%) |
| Dec 2022 | -$34.13 M(+73.5%) | -$10.64 M(-2.8%) | -$34.13 M(+21.2%) |
| Sept 2022 | - | -$10.94 M(+137.9%) | -$28.15 M(+36.2%) |
| June 2022 | - | -$4.60 M(-42.1%) | -$20.66 M(-6.1%) |
| Mar 2022 | - | -$7.94 M | -$22.00 M |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2021 | -$19.67 M(-26.6%) | - | - |
| Dec 2021 | - | -$4.67 M(+34.9%) | -$19.67 M(-8.8%) |
| Sept 2021 | - | -$3.46 M(-41.8%) | -$21.57 M(-14.7%) |
| June 2021 | - | -$5.94 M(+6.0%) | -$25.29 M(+2.6%) |
| Mar 2021 | - | -$5.61 M(-14.7%) | -$24.65 M(-8.0%) |
| Dec 2020 | -$26.80 M(-15.6%) | -$6.57 M(-8.3%) | -$26.80 M(+32.5%) |
| Sept 2020 | - | -$7.17 M(+35.3%) | -$20.23 M(+54.9%) |
| June 2020 | - | -$5.30 M(-31.7%) | -$13.06 M(+68.3%) |
| Mar 2020 | - | -$7.76 M | -$7.76 M |
| Dec 2019 | -$31.74 M(-5.8%) | - | - |
| Dec 2018 | -$33.68 M | - | - |
FAQ
- What is Compass Therapeutics annual cash flow from operations?
- What is the all time high annual CFO for Compass Therapeutics?
- What is Compass Therapeutics annual CFO year-on-year change?
- What is Compass Therapeutics quarterly cash flow from operations?
- What is the all time high quarterly CFO for Compass Therapeutics?
- What is Compass Therapeutics quarterly CFO year-on-year change?
- What is Compass Therapeutics TTM cash flow from operations?
- What is the all time high TTM CFO for Compass Therapeutics?
- What is Compass Therapeutics TTM CFO year-on-year change?
What is Compass Therapeutics annual cash flow from operations?
The current annual CFO of CMPX is -$40.62 M
What is the all time high annual CFO for Compass Therapeutics?
Compass Therapeutics all-time high annual cash flow from operations is -$19.67 M
What is Compass Therapeutics annual CFO year-on-year change?
Over the past year, CMPX annual cash flow from operations has changed by -$6.49 M (-19.03%)
What is Compass Therapeutics quarterly cash flow from operations?
The current quarterly CFO of CMPX is -$11.05 M
What is the all time high quarterly CFO for Compass Therapeutics?
Compass Therapeutics all-time high quarterly cash flow from operations is -$3.46 M
What is Compass Therapeutics quarterly CFO year-on-year change?
Over the past year, CMPX quarterly cash flow from operations has changed by -$5.13 M (-86.61%)
What is Compass Therapeutics TTM cash flow from operations?
The current TTM CFO of CMPX is -$48.05 M
What is the all time high TTM CFO for Compass Therapeutics?
Compass Therapeutics all-time high TTM cash flow from operations is -$7.76 M
What is Compass Therapeutics TTM CFO year-on-year change?
Over the past year, CMPX TTM cash flow from operations has changed by -$9.14 M (-23.50%)